1. Cryo-EM: The Resolution Revolution and Drug Discovery
- Author
-
Fiona Shilliday, Taiana Maia de Oliveira, Lotte van Beek, Judit E. Debreczeni, and Christopher R. Phillips
- Subjects
0301 basic medicine ,Engineering ,Cryo-electron microscopy ,Drug discovery ,business.industry ,Cryoelectron Microscopy ,macromolecular substances ,Computational biology ,Biochemistry ,Analytical Chemistry ,Imaging analysis ,Structure-Activity Relationship ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Structural biology ,Drug Discovery ,Animals ,Humans ,Molecular Medicine ,business ,030217 neurology & neurosurgery ,Biotechnology - Abstract
Single-particle cryogenic electron microscopy (cryo-EM) has been elevated to the mainstream of structural biology propelled by technological advancements in numerous fronts, including imaging analysis and the development of direct electron detectors. The drug discovery field has watched with (initial) skepticism and wonder at the progression of the technique and how it revolutionized the molecular understanding of previously intractable targets. This article critically assesses how cryo-EM has impacted drug discovery in diverse therapeutic areas. Targets that have been brought into the realm of structure-based drug design by cryo-EM and are thus reviewed here include membrane proteins like the GABAA receptor, several TRP channels, and G protein-coupled receptors, and multiprotein complexes like the ribosomes, the proteasome, and eIF2B. We will describe these studies highlighting the achievements, challenges, and caveats.
- Published
- 2021
- Full Text
- View/download PDF